A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome

Clinical trial NCT00774007 · COMPLETED

Trial details

NCT number: NCT00774007
Sponsor: SOFAR S.p.A.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2004-09-01
Primary completion: 2005-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.